NORTHERN TRUST CORP - CNS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CNS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$6,000
-33.3%
32,0940.0%0.00%
Q2 2022$9,000
-18.2%
32,0940.0%0.00%
Q1 2022$11,000
-52.2%
32,0940.0%0.00%
Q4 2021$23,000
-52.1%
32,0940.0%0.00%
Q3 2021$48,000
-23.8%
32,0940.0%0.00%
Q2 2021$63,000
-18.2%
32,0940.0%0.00%
Q1 2021$77,00032,0940.00%
Other shareholders
CNS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 534,148$951,0000.36%
CVI Holdings, LLC 415,652$740,0000.14%
ESSEX INVESTMENT MANAGEMENT CO LLC 61,307$109,0000.01%
Warberg Asset Management LLC 14,000$25,0000.01%
Alpha Cubed Investments, LLC 10,000$18,0000.00%
Integrated Advisors Network LLC 10,700$19,0000.00%
Core Wealth Advisors, Inc. 550$1,0000.00%
OSAIC HOLDINGS, INC. 5,000$9,0000.00%
WELLS FARGO & COMPANY/MN 41$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CNS PHARMACEUTICALS INC shareholders